FIVELITERS Trademark
Trademark Overview
On Wednesday, July 9, 2025, a trademark application was filed for FIVELITERS with the United States Patent and Trademark Office. The USPTO has given the FIVELITERS trademark a serial number of 99275192. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, May 25, 2026. This trademark is owned by Spark Biomedical, Inc.. The FIVELITERS trademark is filed in the Medical Instrument Products and Computer & Software Services & Scientific Services categories with the following description:
Providing medical and scientific research information in the field of clinical trials
Medical apparatus for use in treating blood loss reduction and bleeding disorders; Medical devices, namely, pulse generators for neurostimulation for blood loss reduction and treatment of bleeding disorders; Non-invasive medical devices for use in treating blood loss reduction and bleeding disorders; Medical devices for use in treating blood loss reduction and bleeding disorders
General Information
| Serial Number | 99275192 |
| Word Mark | FIVELITERS |
| Filing Date | Wednesday, July 9, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, May 25, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 16, 2026 |
Trademark Statements
| Goods and Services | Providing medical and scientific research information in the field of clinical trials |
| Pseudo Mark | FIVE LITERS |
| Goods and Services | Medical apparatus for use in treating blood loss reduction and bleeding disorders; Medical devices, namely, pulse generators for neurostimulation for blood loss reduction and treatment of bleeding disorders; Non-invasive medical devices for use in treating blood loss reduction and bleeding disorders; Medical devices for use in treating blood loss reduction and bleeding disorders |
Classification Information
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 9, 2025 |
| Primary Code | 010 |
| First Use Anywhere Date | Thursday, June 30, 2022 |
| First Use In Commerce Date | Thursday, June 30, 2022 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 9, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, June 30, 2022 |
| First Use In Commerce Date | Thursday, June 30, 2022 |
Trademark Owner History
| Party Name | Spark Biomedical, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Dallas, TX 75252
US |
Trademark Events
| Event Date | Event Description |
| Wednesday, July 9, 2025 | NEW APPLICATION ENTERED |
| Wednesday, July 9, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, November 14, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 28, 2025 | ASSIGNED TO EXAMINER |
| Thursday, December 4, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, December 4, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, December 4, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, February 24, 2026 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Tuesday, February 24, 2026 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Friday, May 15, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, May 15, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 15, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, May 16, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 10, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
